AG-013736
Drug timelines are a Plus or Pro feature.
17 regulatory and trial events tracked for AG-013736, covering 2009-08-04 to 2013-11-25. Get the full timeline:
Most recent: Clinical Trial Update: Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer [Phase 2]